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1. Introduction 
Immunoglobulin E (IgE), a minor class of human 
serum proteins [l] , plays an important role as media- 
tor in various hypersensitivity reactions of the imme- 
diate type [2] . IgE binds firmly to membrane recep- 
tors on basophilic leucocytes and mast cells via its Fc- 
portion [3,4] . A study on the structure of this region 
of the IgE molecule is therefore of interest and in the 
present paper a comparison is made between the 
amino acid sequences of the C-terminal domains of E-, 
y- and p- chains. 
2. Materials and methods 
IgE myeloma protein was isolated from the serum 
of patient ND by salting-out (Na,SO,) and further 
purified by ion-exchange chromatography and gel fil- 
tration as previously described [2]. 
For cyanogen bromide cleavage 5 pmoles of lyo- 
philized IgE was dissolved in 70% formic acid and 
CNBr added to give a CNBr:protein ratio (w/w) of 
1:2. After 12 hr at room temp. the solution was di- 
luted four times with water and lyophilized. The prod- 
uct was redissolved in 1 M HAc-25 mM NaCl and frac- 
tionated on Sephadex G-100 in the same solvent. 
Only two peaks were obtained; the first, major peak 
eluted with the void volume and the second peak with 
a V,/VT of 0.61. The latter peak, which yields about 
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12% of the applied amount, was reduced with dithio- 
threitol(20 mM) in 6 M guanidine-HCl-0.1 M Tris- 
HCl pH 8 for 60 min at room temp., alkylated with 
[14C] iodoacetate, specific activity 1.35 mCi/mM, and 
the product fractionated on Sephadex G-50 in 1 M 
acetic acid-25 mM NaCl. Two new fragments were 
obtained and designated ~2 and ~4. Tryptic cleavage 
of the fragments was done in 1% NH4HC03 for 8 hr 
at 37°C using an enzyme:substrate ratio of 1: 100. 
Peptic cleavage of the fragments was done in 0.02 N 
HCl for 14 hr at 37°C using an enzyme: substrate ratio 
of 1:50. 
The digests (1 pmole) were fractionated by paper 
electrophoresis at pH 6.5 followed by purification of 
peptides by paper chromatography in butanol,acetic 
acid-water-pyridine (15: 3: 12: 10) and paper electro- 
phoresis at pH 3.5. 
The peptides were analyzed and then subjected to 
the dansyl-Edman procedure as described previously 
[5,61. 
Automatic amino-terminal sequence determination 
[7] was carried out on a Beckman 890 Sequencer, US- 
ing Beckman chemicals. 800 nmoles of ~2 was sub- 
jected to fifty cycles of degradation with the standard 
double-cleavage programme. ~4 (1 pmole) was de- 
graded using a single-cleavage programme designed to 
reduce extractive losses: the Quadrol buffer was di- 
luted to 0.25 M with propan-2-ol:water (3:2, v/v), the 
coupling time increased to 30 min and the ethyl ace- 
tate wash reduced to 400 sec. The use of thiol 
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Fig. 1. Sequencer yields of e2-fragment. 
additives and the identification of PTH-amino acids 
were as described previously [8] . 
3. Results and discussion 
The amino acid composition of fragment ~2 did 
not contain homoserine, indicating that ~2 is the C- 
terminal fragment of the e-chain. The results of the 
~2 degradation are summarised in fig. 1. The repeti- 
tive yield was about 94%. After the first few residues, 
the overlap sequence, displaced from the main se- 
quence by one residue, can be followed. 
The ~4 sequence was followed for 12 residues and 
gave the results shown in table 1. 
Analysis of the tryptic and peptic peptides by the 
dansyl-Edman procedure permitted the elucidation of 
a continuous sequence accounting for the. C-terminal 
half of the fragment (fig. 2). This, combined with the 
sequencer results gave a continuous sequence for the 
whole of the ~2 fragment in close agreement with the 
amino acid composition of the intact fragment. The 
C-terminal peptide was obtained in two forms in 
about equal yields: c2TN2 which ends with glycine 
and e2TB4b which ends with glycine-lysine. The 
amino acid analysis of intact ~2 also indicates the pres- 
ence of a fractional amount of lysine. The reason for 
this heterogeneity at the C-terminus is obscure, but a 
similar heterogeneity has been observed in a haemo- 
globin variant [9] . It seems likely that this arises from 
a carboxypeptidase B-like activity in serum [IO]. 
The tryptic peptides of the N-terminal half of ~2 
were obtained in lower yields. This is probably due to 
the formation, during tryptic digestion, of an insoluble 
precipitate which is resistant to further cleavage. The 
Table 1 
Sequencer yields of e4-fragment. 
Major Minor** 
Fraction 
Residue (nanomoles) Rksidue (nanomoles) 
1 Arg 400 - - 
2 Ser > 400* _ - 
3 Thr > 170* _ _ 
4 Thr > 170* _ _ 
5 LYS > 200* - - 
6 Thr 100 LYS 32 
7 Ser 370 - - 
8 GlY > 310* - - 
9 Pro 210 _ _ 
10 A.rg 92 Pro 90 
11 Ala 200 Arg 44 
12 Ala < 50 
* Peak off-scale on amino-acid analyser. 
** No values given if the yield was lower than 20% of main 
residue. 
tryptic peptide located between e2TBX and e2TNl 
was never detected (see fig. 2). This peptide contains 
bonds very susceptible to chymotryptic activity 
which, together with the insolubility described above, 
may account for this failure. 
One serine residue in the tryptic peptide e2TBS 
has been marked with an asterisk; during the dansyl- 
Edman procedure this residue gave only a minor 
amount of DNS-serine plus large amounts of a fluores- 
cent component which could not be identified. The 
amino acid composition of the peptide was unequivo- 
cal, which together with the clear cut results obtained 
during the dansyl-Edman procedure permits an assign- 
ment of this residue by difference. The possibility 
that this particular serine residue is modified in some 
way is not excluded. 
The sequence of fragment ~4 was more straightfor- 
ward (fig. 3). All the tryptic peptides could be pre- 
pared in good yields and the automatic sequencer 
data were used for overlapping the first three tryptic 
peptides. In this case the automatic sequencer gave 
reasonable yields for only 12 cycles (fig. 1 b) due to 
the solubility of the remaining fragment in the organ- 
ic solvents. 
Since ~2 and e4 are formed from reductive cleavage 
of a single disulphide-bonded fragment, their unique 
half-cystines must form an intrachain loop. This indi- 
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Fig. 2. The ammo acid sequence of fragment ~2. The continuous line indicates the section of the peptide for which the auto- 
matic sequencer results are shown in fig. 1. Tryptic peptides (e2T) and peptic peptides (e2P) were subjected to the dansyl- 
Edman procedure as indicated by arrows. Double arrows indicate that the residue was obtained as a free ammo acid at the 
end of the degradation. 
cates that they belong to the same domain. When the 
sequences of the ~2 and ~4 fragments are compared 
with the sequence of the C-terminal part of human y- 
and ,u-chains, there are striking homologies (fig. 4), 
which suggests that e4 and ~2 are contiguous and to- 
gether account for the C-terminal domain of the e- 
chain. The data further suggest hat e-chain arose 
early in the evolution of the immunoglobulin chains 
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Fig. 3. Sequence of ~4 fragment. Details as for fig. 2. The two unique half-cystine of the unreduced ~4 and ~2 fragment are linked 
as an intrachain S-S bond. 8 1 7 P CM; E K AL AA P E E l-l - P Q HRMB F A T L P P I I L P P PEW 
Fig. 4. Comparison of the sequence of fragments ~4 and ~2 with the Cy3-domain and the analogous region from cc-chain. The y- 
chain line includes the alternative variants of 71 [ 1 l] and 74 [ 121 human sequences. The human or sequence [ 131 includes some 
unpublished data kindly provided by Dr. F. Putnam. 
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